# Opposite Effects of Diacylglycerol and Phosphatidic Acid in the Modulation of the Plasma Membrane Ca2+-ATPase from Kidney Proximal Tubules: A Regulatory Role for Diacylglycerol Kinase in Calcium Homeostasis?

**Authors:** Gloria M. R. S. Grelle, Pilar A. M. Moreno, Thais A. Bonilha, Osman F. Silva, Rafael Garrett, Fábio Ricardo M. Botelho, Luciana Nogaroli, Rafael H. F. Valverde, Marcelo Einicker-Lamas

PMC · DOI: 10.3390/biomedicines14020388 · Biomedicines · 2026-02-08

## TL;DR

This study explores how two bioactive lipids, diacylglycerol and phosphatidic acid, opposingly regulate calcium transport in kidney cells, suggesting a role for diacylglycerol kinase in calcium balance.

## Contribution

The paper reveals opposing regulatory effects of DG and PA on PMCA activity and identifies a novel DG-DGK-PA axis in calcium signaling under metabolic stress.

## Key findings

- Diacylglycerol inhibits PMCA activity via PKC-dependent phosphorylation.
- Phosphatidic acid stimulates PMCA activity, showing opposing regulation.
- Transcriptomic data suggest DG accumulation and PMCA upregulation under hypoxia.

## Abstract

Background/Objectives: Kidney proximal tubules reabsorb up to 70% of water and solutes from the glomerular ultrafiltrate, a Ca2+-modulated process essential for homeostasis. The plasma membrane Ca2+-ATPase (PMCA) in basolateral membranes (BLMs) plays a pivotal role in maintaining intracellular calcium homeostasis and regulating calcium reabsorption. Methods: Here, we investigated the regulatory influence of two key bioactive lipids, diacylglycerol (DG) and phosphatidic acid (PA), on PMCA activity from pig kidney, accompanied by lipidomic assays and transcriptomic data analyses. Results: Biochemical assays revealed dose- and time-dependent inhibition of PMCA by DG, fully reversed by Calphostin C, implicating PKC activation. Conversely, PA significantly stimulated PMCA activity, demonstrating an opposite regulatory effect. Our targeted lipidomics identified multiple DG species in HK-2 cells, suggesting substrate diversity. Analysis of transcriptomic data for hypoxic versus normoxic HK-2 cells revealed dramatic coordinated regulation of DG/PA metabolism genes, with upregulation of DG-producing enzymes (PLCB1, PLDs) and downregulation of DG-consuming kinases (DGKs), predicting enhanced DG accumulation under metabolic stress. ATP2B4 (PMCA4) upregulation indicated compensatory transcriptional responses. Conclusions: Our findings suggest that DG inhibits BLM-associated PMCA via classic and/or atypical PKC-dependent phosphorylation while PA exerts opposing stimulatory effects. Both transcriptional remodeling and post-translational modifications regulate this axis. These findings highlight the DG–Diacylglycerol Kinase–PA axis as a dynamic modulator of Ca2+ signaling in the kidney that responds to metabolic stress.

## Linked entities

- **Genes:** PLCB1 (phospholipase C beta 1) [NCBI Gene 23236], ATP2B4 (ATPase plasma membrane Ca2+ transporting 4) [NCBI Gene 493]
- **Proteins:** PMCA (plasma membrane calcium ATPase), PRRT2 (proline rich transmembrane protein 2)
- **Chemicals:** diacylglycerol (PubChem CID 6026790), phosphatidic acid (PubChem CID 446066), Calphostin C (PubChem CID 10930781)
- **Species:** Sus scrofa (taxon 9823), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** CALM3 (calmodulin 3) [NCBI Gene 396838], DGKB (diacylglycerol kinase beta) [NCBI Gene 1607] {aka DAGK2, DGK, DGK-BETA}, PKC-delta [NCBI Gene 100126848], ATP2B1 (ATPase plasma membrane Ca2+ transporting 1) [NCBI Gene 397636], DGKG (diacylglycerol kinase gamma) [NCBI Gene 100623595], SLC8A1 (solute carrier family 8 member A1) [NCBI Gene 475738] {aka NCX1}, PKC (protein kinase C lambda) [NCBI Gene 100174947], ENPP2 (ectonucleotide pyrophosphatase/phosphodiesterase 2) [NCBI Gene 503658] {aka PDNP2}, PLD5 (phospholipase D family member 5) [NCBI Gene 100622421], LPIN1 (lipin 1) [NCBI Gene 100170845] {aka lipin1}, PRKCA (protein kinase C alpha) [NCBI Gene 397184], PRKCB (protein kinase C beta) [NCBI Gene 100522792] {aka PKC, PRKCB1, PRKCB_tv2}, PLCB1 (phospholipase C beta 1) [NCBI Gene 100152679], PLD1 (phospholipase D1) [NCBI Gene 100519446], PRKCD (protein kinase C delta) [NCBI Gene 100622955] {aka PKCdelta}, BLM (BLM RecQ like helicase) [NCBI Gene 100141304], TRPV4 (transient receptor potential cation channel subfamily V member 4) [NCBI Gene 100126845], PRKCE (protein kinase C epsilon) [NCBI Gene 100524932], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 100127359] {aka FRAP1}, PRKACA (protein kinase cAMP-activated catalytic subunit alpha) [NCBI Gene 397652] {aka PKA}, ATP2B1 (ATPase plasma membrane Ca2+ transporting 1) [NCBI Gene 403480] {aka PMCA}, ATP2B4 [NCBI Gene 733701], PLPP6 [NCBI Gene 100623955], DGKQ (diacylglycerol kinase theta) [NCBI Gene 100622701], PLPP3 (phospholipid phosphatase 3) [NCBI Gene 100512419]
- **Diseases:** AKI (MESH:D058186), ischemic kidney injury (MESH:D007674), hypoxic (MESH:D002534), obesity (MESH:D009765), sepsis (MESH:D018805), Hypoxia (MESH:D000860), cyst (MESH:D003560), crystal (MESH:D000070657), ischemia (MESH:D007511), polycystic kidney disease (MESH:D007690), injury to (MESH:D014947), inflammation (MESH:D007249), renal tubular injury (MESH:D015499), calcium overload (MESH:D019190), metabolic syndrome (MESH:D024821), ischemia/reperfusion injury (MESH:D015427), cytotoxicity (MESH:D064420), chronic kidney disease (MESH:D051436), ischemic injury (MESH:D017202), ischemic (MESH:D002545)
- **Chemicals:** 3-MCPD (MESH:D000517), lipid (MESH:D008055), phospholipids (MESH:D010743), ATP (MESH:D000255), water (MESH:D014867), NaN3 (MESH:D019810), EGTA (MESH:D004533), CO2 (MESH:D002245), ion (MESH:D007477), ouabain (MESH:D010042), LPA (MESH:C032881), sphingosine (MESH:D013110), ceramide (MESH:D002518), Calcium (MESH:D002118), KCl (MESH:D011189), CaCl2 (MESH:D002122), oleic acid (MESH:D019301), DAG (MESH:D004075), isopropanol (MESH:D019840), 32P (MESH:C000615311), HCl (MESH:D006851), formic acid (MESH:C030544), inorganic phosphate (MESH:D010710), Pi (MESH:D010716), charcoal (MESH:D002606), Na (MESH:D012964), phorbol ester (MESH:D010703), MgCl2 (MESH:D015636), PBS (-), R59949 (MESH:C058544), methanol (MESH:D000432), BisTris propane (MESH:C034249), acetonitrile (MESH:C032159), trichloroacetic acid (MESH:D014238), Dioleoylglycerol (MESH:C013965), PA (MESH:D010712), carbons (MESH:D002244), acetone (MESH:D000096), fatty acid (MESH:D005227), phosphatidylcholine (MESH:D010713), Calphostin C (MESH:C058819), nitrogen (MESH:D009584), PMA (MESH:D013755)
- **Species:** Cladosporium cladosporioides (species) [taxon 29917], Sus scrofa (pig, species) [taxon 9823], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** MDCK — Canis lupus familiaris (Dog), Spontaneously immortalized cell line (CVCL_0422)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938839/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938839/full.md

## References

67 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938839/full.md

---
Source: https://tomesphere.com/paper/PMC12938839